{"id":7927,"date":"2020-02-06T17:00:01","date_gmt":"2020-02-06T11:30:01","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=7927"},"modified":"2023-02-10T12:24:56","modified_gmt":"2023-02-10T06:54:56","slug":"recent-pharma-happenings-for-regeneron-fda-contura","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-regeneron-fda-contura","title":{"rendered":"Immune cells for age-related diseases;  Regeneron&#8217;s antibody for 2019-nCoV; FDA nods for hydrogel injection"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\" id=\"h-activated-immune-cells-responsible-for-improving-age-related-diseases\"><strong>Activated immune cells responsible for improving age-related diseases&nbsp;<\/strong><\/h3>\n\n\n\n<p>The main culprits of the inflammatory responses associated with <a href=\"https:\/\/www.delveinsight.com\/report-store\/asthma-market\">asthma <\/a>are Interleukins IL-33 and IL-5. There has been researching going on, and the researchers at Albany Medical College discovered that if these two signalling molecules are to be linked to a type of immune cell in the brain, it might alleviate age-related diseases and help in the treatment of neurodegenerative diseases.<\/p>\n\n\n\n<p>The class of immune cell is known as group 2 innate lymphoid cells (ILC2s). The scientists stated that when old mice were treated with IL-33 to activate ILC2 or use IL-5\u2014which is a product of ILC2 activation\u2014showed improvement in cognition among the animals as per the report that has been published in the Journal of Experimental Medicine.<br><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-regeneron-turns-antibody-capabilities-for-2019-ncov\"><strong>Regeneron turns antibody capabilities for 2019-nCoV&nbsp;<\/strong><\/h3>\n\n\n\n<p>Regeneron Pharmaceuticals, an American biotechnology company, focuses on neurotrophic factors and their regenerative capabilities. The company has collaborated with the U.S. Department of Health and Human Services (HHS) to produce the <a href=\"https:\/\/www.delveinsight.com\/blog\/coronavirus\">coronavirus <\/a>treatment. The alliance will take advantage of Regeneron antibody technology that has given an effective treatment for the Ebola outbreak.&nbsp; &nbsp;&nbsp;<\/p>\n\n\n\n<p>Regeneron and the HHS\u2019 Office of the Assistant Secretary for Preparedness and Response (ASPR) focus on producing multiple monoclonal antibodies, which proffer treatment of the 2019-nCoV coronavirus when given as monotherapies or in combination. They plan to develop antibodies which will bind to viral proteins and eventually prohibit the pathogen from infecting human cells.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-fda-nods-head-to-hydrogel-injection-for-stress-urinary-incontinence\"><strong>FDA nods head to hydrogel injection for stress urinary incontinence<\/strong><\/h3>\n\n\n\n<p>The FDA has given a green signal for the injection of soft hydrogel spacers that are designed to bolster the walls of the urethra in women, who are suffering from stress <a href=\"https:\/\/www.delveinsight.com\/report-store\/urinary-incontinence-market\">urinary incontinence<\/a>. The injections aim to stop urine leakage by strengthening the urethra\u2019s volume and increasing its natural closing pressure.<\/p>\n\n\n\n<p>The London-based Contura develops the Bulkamid hydrogel also functions as a scaffold for growing cells, to proffer ever-lasting treatment. The injection was first approved with a CE mark in 2003, and the company had claimed to treat the affected women with stress <a href=\"https:\/\/www.delveinsight.com\/report-store\/urinary-incontinence-global-api-manufacturers-marketed-and-phase-iii-drugs-landscape\">urinary incontinence<\/a> over 70,000 women to date in more than 25 countries.<br><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Activated immune cells responsible for improving age-related diseases&nbsp; The main culprits of the inflammatory responses associated with asthma are Interleukins IL-33 and IL-5. There has been researching going on, and the researchers at Albany Medical College discovered that if these two signalling molecules are to be linked to a type of immune cell in the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":7928,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":1,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[32],"tags":[2440,1875,7860,349,639,5789,1510,18018],"industry":[17225],"therapeutic_areas":[17245,17243],"class_list":["post-7927","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizia","tag-age-related-diseases","tag-asthma","tag-coronavirus-treatment","tag-latest-pharma-news","tag-pharma-news","tag-recent-pharma-news","tag-regeneron-pharmaceuticals","tag-stress-urinary-incontinence","industry-pharmaceutical","therapeutic_areas-neurology","therapeutic_areas-respiratory-diseases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma News and Updates | Regeneron Pharma, Contura<\/title>\n<meta name=\"description\" content=\"Immune cells for age-related diseases research update; Regeneron\u2019s antibody for 2019-nCoV; FDA nods for hydrogel injection\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-regeneron-fda-contura\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma News and Updates | Regeneron Pharma, Contura\" \/>\n<meta property=\"og:description\" content=\"Immune cells for age-related diseases research update; Regeneron\u2019s antibody for 2019-nCoV; FDA nods for hydrogel injection\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-regeneron-fda-contura\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-02-06T11:30:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-10T06:54:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/02\/06164148\/slide2-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"772\" \/>\n\t<meta property=\"og:image:height\" content=\"482\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma News and Updates | Regeneron Pharma, Contura","description":"Immune cells for age-related diseases research update; Regeneron\u2019s antibody for 2019-nCoV; FDA nods for hydrogel injection","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-regeneron-fda-contura","og_locale":"en_US","og_type":"article","og_title":"Pharma News and Updates | Regeneron Pharma, Contura","og_description":"Immune cells for age-related diseases research update; Regeneron\u2019s antibody for 2019-nCoV; FDA nods for hydrogel injection","og_url":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-regeneron-fda-contura","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2020-02-06T11:30:01+00:00","article_modified_time":"2023-02-10T06:54:56+00:00","og_image":[{"width":772,"height":482,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/02\/06164148\/slide2-1.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-regeneron-fda-contura","url":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-regeneron-fda-contura","name":"Pharma News and Updates | Regeneron Pharma, Contura","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-regeneron-fda-contura#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-regeneron-fda-contura#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/02\/06164148\/slide2-1.jpg","datePublished":"2020-02-06T11:30:01+00:00","dateModified":"2023-02-10T06:54:56+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Immune cells for age-related diseases research update; Regeneron\u2019s antibody for 2019-nCoV; FDA nods for hydrogel injection","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-regeneron-fda-contura"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/recent-pharma-happenings-for-regeneron-fda-contura#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/02\/06164148\/slide2-1.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/02\/06164148\/slide2-1.jpg","width":772,"height":482,"caption":"Pharma News"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2020\/02\/06164148\/slide2-1-300x187.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Notizia - Recent Pharma, Healthcare and Biotech Happenings<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Notizia - Recent Pharma, Healthcare and Biotech Happenings<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">age-related diseases<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">asthma<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Coronavirus Treatment<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Latest pharma news<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">pharma news<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">recent pharma news<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Regeneron Pharmaceuticals<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Stress Urinary Incontinence<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">age-related diseases<\/span>","<span class=\"advgb-post-tax-term\">asthma<\/span>","<span class=\"advgb-post-tax-term\">Coronavirus Treatment<\/span>","<span class=\"advgb-post-tax-term\">Latest pharma news<\/span>","<span class=\"advgb-post-tax-term\">pharma news<\/span>","<span class=\"advgb-post-tax-term\">recent pharma news<\/span>","<span class=\"advgb-post-tax-term\">Regeneron Pharmaceuticals<\/span>","<span class=\"advgb-post-tax-term\">Stress Urinary Incontinence<\/span>"]}},"comment_count":"1","relative_dates":{"created":"Posted 6 years ago","modified":"Updated 3 years ago"},"absolute_dates":{"created":"Posted on Feb 6, 2020","modified":"Updated on Feb 10, 2023"},"absolute_dates_time":{"created":"Posted on Feb 6, 2020 5:00 pm","modified":"Updated on Feb 10, 2023 12:24 pm"},"featured_img_caption":"Pharma News","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/7927","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=7927"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/7927\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/7928"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=7927"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=7927"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=7927"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=7927"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=7927"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}